Your browser doesn't support javascript.
loading
Enhanced Cancer Immunotherapy with Smad3-Silenced NK-92 Cells.
Wang, Qing-Ming; Tang, Patrick Ming-Kuen; Lian, Guang-Yu; Li, Chunjie; Li, Jinhong; Huang, Xiao-Ru; To, Ka-Fai; Lan, Hui-Yao.
Afiliación
  • Wang QM; Li Ka Shing Institute of Health Sciences, Department of Medicine & Therapeutics, and Lui Che Woo Institute of Innovative Medicine, The Chinese University of Hong Kong, Hong Kong SAR, China.
  • Tang PM; Department of Hematology, The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China.
  • Lian GY; Li Ka Shing Institute of Health Sciences, Department of Medicine & Therapeutics, and Lui Che Woo Institute of Innovative Medicine, The Chinese University of Hong Kong, Hong Kong SAR, China.
  • Li C; Department of Anatomical and Cellular Pathology, State Key Laboratory of Oncology in South China, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong, China.
  • Li J; Li Ka Shing Institute of Health Sciences, Department of Medicine & Therapeutics, and Lui Che Woo Institute of Innovative Medicine, The Chinese University of Hong Kong, Hong Kong SAR, China.
  • Huang XR; Li Ka Shing Institute of Health Sciences, Department of Medicine & Therapeutics, and Lui Che Woo Institute of Innovative Medicine, The Chinese University of Hong Kong, Hong Kong SAR, China.
  • To KF; Li Ka Shing Institute of Health Sciences, Department of Medicine & Therapeutics, and Lui Che Woo Institute of Innovative Medicine, The Chinese University of Hong Kong, Hong Kong SAR, China.
  • Lan HY; Li Ka Shing Institute of Health Sciences, Department of Medicine & Therapeutics, and Lui Che Woo Institute of Innovative Medicine, The Chinese University of Hong Kong, Hong Kong SAR, China.
Cancer Immunol Res ; 6(8): 965-977, 2018 08.
Article en En | MEDLINE | ID: mdl-29915022
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Asunto principal: Melanoma Experimental / Células Asesinas Naturales / Proteína smad3 / Inmunoterapia / Neoplasias Hepáticas Experimentales Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: Cancer Immunol Res Año: 2018 Tipo del documento: Article País de afiliación: China
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Asunto principal: Melanoma Experimental / Células Asesinas Naturales / Proteína smad3 / Inmunoterapia / Neoplasias Hepáticas Experimentales Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: Cancer Immunol Res Año: 2018 Tipo del documento: Article País de afiliación: China